National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 02:51:38
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44206-451-01 | ML - Milliliter | 44206-451 | d81cacc7-eb42-4493-9a5e-d1df6ae54f76 | 1 | 2012-07-24 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 44206-451 | 44206-451-01 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125350 | Hizentra | Immune Globulin Subcutaneous (Human), 20% Liquid | 351(a) | Rx | 2026-10-01 |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hizentra | HUMAN IMMUNOGLOBULIN G | CSL Behring AG | 7b58f5ff-0316-49a3-b585-1f6003ddb953 | 2023-04-20 | Boxed warning, Warnings, Adverse reactions | 44206-451-01 44206045101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.